INJECTABLE RICOBENDAZOLE 10

INJECTABLE RICOBENDAZOLE 10

_________________________________________________________Veterinary Use

 Formula:
  Each 100 ml contains:
  Albendazole sulphoxide.....................................10.00 g
  Vehicle q.s.p..............................................100.00 ml

Indication:
Injectable Ricobendazole 10 is a broad-spectrum antihelminthic acting on the sterilization of the eggs and against the adult and immature forms of the following Nematodes, Cestodes and Trematodes that affect bovines:

Gastrointestinal nematodes:
Haemonchus spp, Ostertagia spp (including larval hypobiosis – Type II Ostertagiosis), Trichostrongylus spp, Cooperia spp, Nematodirus spp, Oesophagostomum spp, Trichuris spp, Chabertia spp, Strongyloides spp, Bunostomum spp.

Pulmonary nematode:
Dictyocaulus viviparus

 

Cestode:
Moniezia spp

Trematode:
Fasciola hepatica – adult form.
Complementary indication:
Auxiliary in the control of bovine cysticercosis (Cysticercus bovis).

Mode of use and dosage:
Injectable Ricobendazole 10 should be administered through subcutaneous route, at a single dose, using a dosing pistol, according to the table below:
Dosing table:

Body weight

Nematodes and Cestodes

Type II Ostertagiosis

Fasciola hepatica

40 kg

1.0 ml

1.5 ml

2.0 ml

80 kg

2.0 ml

3.0 ml

4.0 ml

120 kg

3.0 ml

4.5 ml

6.0 ml

160 kg

4.0 ml

6.0 ml

8.0 ml

240 kg

6.0 ml

9.0 ml

12.0 ml

320 kg

8.0 ml

12.0 ml

16.0 ml

400 kg

10.0 ml

15.0 ml

20.0 ml

 

1 ml / 40 kg

1.5 ml / 40 kg

2 ml / 40 kg

As an auxiliary in the control of bovine cysticercosis:
The indicated dose is 2.5 mg of albendazol sulphoxide per kg of body weight, i.e.,1 ml per 40 kg, according to the schedule below:
Administer the product for three times with a 30-day interval between each administration, i.e., 3 administrations on a 30 – 60 and 90 days schedule.
Following the last administration, the 14-day withdrawal time should be followed prior to slaughtering.

Contraindication and use limitations:
The product should only be administered to bovines.
The product should only be administered through subcutaneous (SC) route, preferably in the neck region.

Adverse effects:
The product does not cause adverse effects when following the dosages indicated for use.

Precautions:
Follow the dosages recommended for the product use.
Doses that are higher than 10 ml should be divided into two or more administration sites.
Use the appropriate needles for subcutaneous administration and aseptic syringes.
Empty packages should be buried or burnt

Withdrawal time:
Meat from treated animals should not be intended for human consumption prior to 14 days from the time the product was last administered.
Milk from treated animals should not be intended for human consumption prior to 72 hours from the time the product was administered.
Keep the product in a dry and cool place, between 5º C and 30º C, protected from sunlight, out of the reach of children and pets.
To be sold under prescription and administered under the veterinarian’s instructions.
Technical Responsible:
Dr. Fausto Eduardo Fonseca Terra
CRMV/SP – 10.300
Licensed by the Ministry of Agriculture under no. 7.173 on 12/16/99.

Pharmaceutical form:
Amber glass vials containing 100 ml, 250 ml and 500 ml, and plastic vial containing 1 l.

OUROFINO Saúde Animal

A 100% Brazilian company, exporter,
generating employment opportunities in Brazil.
Owner and manufacturer:
Ouro Fino Saúde Animal Ltda.
Rod. Anhangüera SP 330 KM 298
CEP: 14140-000 – Cravinhos – SP
CNPJ:57.624.462/0001-05
Tel/Fax: (16) 3518-2000
www.ourofino.com

Made in Brazil